TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31049919

Group type: EXPERIMENTAL
Intervention: Stabilization exercise program for six weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Radiofrequency denervation
Number of subjects: 39
Study: 29142554

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 units per day orally)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 25296344

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) of the quadriceps muscle, twice daily for 7±1 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control leg (non-stimulated)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 6
Study: 24912899

Group type: EXPERIMENTAL
Intervention: 2 years of trastuzumab (n = 1,673)
Number of subjects: 5102

Group type: EXPERIMENTAL
Intervention: 1 year of trastuzumab (n = 1,682)
Number of subjects: 5102

Group type: EXPERIMENTAL
Intervention: 2 years of trastuzumab
Number of subjects: 5102

Group type: EXPERIMENTAL
Intervention: 1 year of trastuzumab
Number of subjects: 5102

Group type: COMPARATOR
Intervention: Observation (n = 1,744)
Number of subjects: 5102

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 5102
Study: 22746261

Group type: EXPERIMENTAL
Intervention: Teen Online Problem Solving (TOPS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Internet Resource Comparison (IRC)
Number of subjects: 41
Study: 18855801

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 17300627

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) prophylaxis (500 mg phosphate weekly)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) prophylaxis
Number of subjects: 1000
Study: 15199346

Group type: EXPERIMENTAL
Intervention: Full-dose tenecteplase plus enoxaparin
Number of subjects: 6095

Group type: EXPERIMENTAL
Intervention: Half-dose tenecteplase plus abciximab
Number of subjects: 6095

Group type: COMPARATOR
Intervention: Full-dose tenecteplase plus unfractionated heparin
Number of subjects: 6095

Group type: COMPARATOR
Intervention: Comparison of enoxaparin versus heparin
Number of subjects: 6095

Group type: COMPARATOR
Intervention: Comparison of abciximab versus heparin
Number of subjects: 6095
Study: 11779753

Group type: EXPERIMENTAL
Intervention: L-bandage
Number of subjects: 68

Group type: COMPARATOR
Intervention: S-bandage
Number of subjects: 68
Study: 9521232

Group type: EXPERIMENTAL
Intervention: Vitamin E (50 mg)
Number of subjects: 27271

Group type: EXPERIMENTAL
Intervention: Beta carotene (20 mg)
Number of subjects: 27271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27271
Study: 7666123

Group type: EXPERIMENTAL
Intervention: ampicillin/sulbactam (2 g ampicillin plus 1 g sulbactam intravenously every 6 h)
Number of subjects: 53

Group type: COMPARATOR
Intervention: cefotaxime (2 g intravenously every 6 h)
Number of subjects: 53
Study: 2533973

Group type: EXPERIMENTAL
Intervention: ANF 102-126 (WY 47987) bolus injections at 1, 2, and 3 micrograms/kg i.v.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 160068

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (2 puffs of 0.02 mg each)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fenoterol (2 puffs of 0.2 mg each)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Isoprenaline (inhaled at the end of the experiment)
Number of subjects: 6
Study: 30496870

Group type: EXPERIMENTAL
Intervention: Live attenuated hepatitis A vaccine (HA-L)
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (HA-I)
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: Both HA-L and HA-I vaccines
Number of subjects: 9000
Study: 27933450

Group type: EXPERIMENTAL
Intervention: mHealth with pedometer
Number of subjects: 356

Group type: COMPARATOR
Intervention: Conventional exercise program using brochure
Number of subjects: 356
Study: 24862305

Group type: EXPERIMENTAL
Intervention: Endurance training and heavy strength training (ES)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Endurance training only (E)
Number of subjects: 16
Study: 23589562

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (activated 1 month after device implantation)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (activated 6 months after device implantation)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (both groups)
Number of subjects: 322
Study: 16886724

Group type: EXPERIMENTAL
Intervention: risperidone (2.5 +/- 1 mg/day)
Number of subjects: 9
Study: 15181130

Group type: EXPERIMENTAL
Intervention: (18)F‐FDG PET
Number of subjects: 21

Group type: COMPARATOR
Intervention: Clinical and US examinations
Number of subjects: 21
Study: 10639180

Group type: EXPERIMENTAL
Intervention: Theta oscillations observed in left hippocampus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theta oscillations observed in right hippocampus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus-locked theta duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hippocampal theta involvement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticipatory phase reset of theta
Number of subjects: 0
Study: 8841148

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Quinidine (200 mg)
Number of subjects: 12
Study: 1462609

Group type: EXPERIMENTAL
Intervention: Biofragmentable Anastomosis Ring (Valtrac‐BAR)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Manual suture (3‐0 Dexon, two layers)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups (BAR and manual suture)
Number of subjects: 170
Study: 6397578

Group type: COMPARATOR
Intervention: Radiotherapy 3000 rad/10 fractions (treatment 1)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus metronidazole 6 gm/m2 (treatment 2)
Number of subjects: 116
Study: 31969072

Group type: EXPERIMENTAL
Intervention: smRSq
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mRS
Number of subjects: 0
Study: 31405867

Group type: EXPERIMENTAL
Intervention: Omadacycline 100 mg i.v.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omadacycline 300 mg i.v.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (negative control)
Number of subjects: 0
Study: 29126170

Group type: EXPERIMENTAL
Intervention: Faith-integrated program (FI)
Number of subjects: 465

Group type: COMPARATOR
Intervention: Self-guided control program (C)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Non-faith integrated program (NFI)
Number of subjects: 465
Study: 25619634

Group type: COMPARATOR
Intervention: Standard clinical practice (Control)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Group 2 (greater patient involvement with reminders)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Group 3 (greater patient involvement with reminders plus regular phone calls and meetings)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Weekly drug administration
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Monthly drug administration
Number of subjects: 334
Study: 23080361

Group type: EXPERIMENTAL
Intervention: Self-report measure of attitudes toward sexual partner concurrency
Number of subjects: 370
Study: 22170276

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (STN-DBS)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 119
Study: 19368768

Group type: EXPERIMENTAL
Intervention: Split H7N1 virus vaccine with 12 microg haemagglutinin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Split H7N1 virus vaccine with 24 microg haemagglutinin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Split H7N1 virus vaccine with 12 microg haemagglutinin and 300 microg aluminium hydroxide adjuvant
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Split H7N1 virus vaccine with 24 microg haemagglutinin and 600 microg aluminium hydroxide adjuvant
Number of subjects: 60
Study: 16448520

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg once daily for 24 weeks
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg once daily for 24 weeks
Number of subjects: 690
Study: 12633795

Group type: EXPERIMENTAL
Intervention: Niacin ER/lovastatin 1,000/40 mg
Number of subjects: 315

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 315

Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Niacin ER/lovastatin
Number of subjects: 315

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg and Simvastatin 20 mg
Number of subjects: 315
Study: 10835443

Group type: EXPERIMENTAL
Intervention: Ethanol in fruit juice (1.5 g/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fruit juice alone (control)
Number of subjects: 12
Study: 8671103

Group type: EXPERIMENTAL
Intervention: Medical Interview Satisfaction Scale (MISS)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Consultation Satisfaction Questionnaire (CSQ)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Correlation between overall scales (MISS and CSQ)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Reliability of MISS
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Reliability of CSQ
Number of subjects: 198

Group type: COMPARATOR
Intervention: Patient satisfaction scores based on completion location
Number of subjects: 198
Study: 1532187

Group type: EXPERIMENTAL
Intervention: Identical, related, and unrelated primes presented for 60, 45, or 30 ms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random letter string (in place of identical prime) with prime durations of 39, 30, or 21 ms
Number of subjects: 0
Study: 3923748

Group type: EXPERIMENTAL
Intervention: Extradural blockade for 24 h
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no extradural blockade)
Number of subjects: 16
Study: 30702055

Group type: EXPERIMENTAL
Intervention: Interpersonal and behavioral activation psychotherapy
Number of subjects: 150
Study: 29265546

Group type: EXPERIMENTAL
Intervention: MRgFUS thalamotomy
Number of subjects: 76
Study: 27473384

Group type: EXPERIMENTAL
Intervention: Epoetin Hospira
Number of subjects: 81

Group type: COMPARATOR
Intervention: Epogen
Number of subjects: 81
Study: 24380989

Group type: EXPERIMENTAL
Intervention: Erythromycin (125 mg in normal saline 50 cc)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo saline
Number of subjects: 114
Study: 22359078

Group type: EXPERIMENTAL
Intervention: Vitex agnus castus (40 drops, administered for 6 days before menses for 6 consecutive cycles)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo (matching placebo administered for 6 days before menses for 6 consecutive cycles)
Number of subjects: 128
Study: 20664534

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 11
Study: 17629361

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 23-valent pneumococcal polysaccharide vaccine (23vPS)
Number of subjects: 15
Study: 15897479

Group type: EXPERIMENTAL
Intervention: High carbohydrate (CHO)/low fat (LF) diet (60% CHO, 20% fat)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low carbohydrate (LC)/high fat (HF) diet (40% CHO, 40% fat)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Overall changes in insulin sensitivity (Si)
Number of subjects: 21
Study: 12451200

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10509204

Group type: EXPERIMENTAL
Intervention: Holmium:YAG laser (0.5 to 1.5 joules per pulse, 5 and 25 Hertz, total energy 1 to 2 K joules)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventionally instrumented group
Number of subjects: 55
Study: 8545140

Group type: EXPERIMENTAL
Intervention: Strong opioid agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of paracetamol and codeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment suggestions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physicians' experience
Number of subjects: 0
Study: 1835005

Group type: EXPERIMENTAL
Intervention: Norethisterone, 5 mg three times a day from day 19 to 26
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Danazol, 200 mg daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Norethisterone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Danazol
Number of subjects: 24
Study: 7129917

Group type: EXPERIMENTAL
Intervention: Endoureteral manipulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Anti-inflammatory drugs and analgesics
Number of subjects: 30
Study: 30887768

Group type: EXPERIMENTAL
Intervention: Total laparoscopic radical hysterectomy (TLRH) with no-look no-touch technique
Number of subjects: 163

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (ARH)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Total laparoscopic radical hysterectomy (TLRH)
Number of subjects: 163
Study: 27671975

Group type: EXPERIMENTAL
Intervention: Action planning condition
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Preparatory planning condition
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard information control condition
Number of subjects: 243
Study: 26021958

Group type: EXPERIMENTAL
Intervention: Acupuncture (12 sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture (12 sessions)
Number of subjects: 30
Study: 23522993

Group type: EXPERIMENTAL
Intervention: Silicone-hydrogel contact lenses worn full time for six months
Number of subjects: 60
Study: 21536455

Group type: EXPERIMENTAL
Intervention: Strong Healthy Women intervention
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 362
Study: 19527160

Group type: EXPERIMENTAL
Intervention: Standard briefing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard briefing plus mnemonic
Number of subjects: 0
Study: 17619851

Group type: EXPERIMENTAL
Intervention: TURIS (Olympus, SurgMasterSystem)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Conventional TUR
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: TURIS
Number of subjects: 128
Study: 13680073

Group type: EXPERIMENTAL
Intervention: Rapid tryptophan depletion (RTD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham session (placebo)
Number of subjects: 14
Study: 11216318

Group type: EXPERIMENTAL
Intervention: Counter-example condition (decreasing numbers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original version (increasing numbers)
Number of subjects: 0
Study: 9046253

Group type: EXPERIMENTAL
Intervention: Ahmed Glaucoma Valve implant
Number of subjects: 21
Study: 7639371

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 0.2 mg/kg loading dose followed by 0.5 mg.kg-1.h-1 infusion
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 0.4 mg/kg loading dose followed by 1 mg.kg-1.h-1 infusion
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 0.5 mg/kg loading dose followed by 2 mg.kg-1.h-1 infusion
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Propofol infusion at 0.7 mg/kg loading dose followed by 4 mg.kg-1.h-1 infusion
Number of subjects: 98
Study: 3064648

Group type: EXPERIMENTAL
Intervention: red rubber tubes (HPC)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: latex-spiral tubes (HPC)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: PVC tubes (LPC)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: PVC tubes with rediffusion system (LPC)
Number of subjects: 500

Group type: COMPARATOR
Intervention: face mask
Number of subjects: 500
Study: 30351388

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with dairy foods (MedDairy)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low-fat (LF) control diet
Number of subjects: 41
Study: 27726525

Group type: EXPERIMENTAL
Intervention: Intervention group with weekly face‐to‐face meetings to reduce BPA exposures, provided with BPA‐free cosmetics, hygiene products, glass containers, and self-monitoring tools
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 26185417

Group type: COMPARATOR
Intervention: 0.2 mg/kg every other week (EOW)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg weekly
Number of subjects: 44

Group type: COMPARATOR
Intervention: 0.2 mg/kg EOW
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg weekly
Number of subjects: 44
Study: 23394779

Group type: EXPERIMENTAL
Intervention: GnRHa stimulation protocol (triptorelin on alternate days, recombinant FSH, and recombinant hCG microdose)
Number of subjects: 96

Group type: COMPARATOR
Intervention: GnRHant protocol (daily dose of recombinant FSH, cetrorelix, and rhCG microdose)
Number of subjects: 96
Study: 20192725

Group type: EXPERIMENTAL
Intervention: BID (400 mg lopinavir and 100 mg ritonavir twice daily)
Number of subjects: 321

Group type: COMPARATOR
Intervention: QD (800 mg lopinavir and 200 mg ritonavir once daily)
Number of subjects: 321
Study: 18336483

Group type: EXPERIMENTAL
Intervention: remifentanil 1.0 microg x kg(‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: saline (group S)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: remifentanil 0.5 microg x kg(‐1) (group R 0.5)
Number of subjects: 60
Study: 16526127

Group type: EXPERIMENTAL
Intervention: Bisphosphonates (etidronate, alendronate, risedronate, clodronate)
Number of subjects: 18667

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18667
Study: 12934762

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (group I)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Balloon dilation (group II)
Number of subjects: 41
Study: 10381291

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day for 6 weeks
Number of subjects: 7
Study: 8963837

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LCE)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional cholecystectomy (CCE)
Number of subjects: 58
Study: 1986973

Group type: EXPERIMENTAL
Intervention: Salpingotomy without tubal suturing
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Salpingotomy with tubal suturing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Salpingectomy (historical control)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Salpingotomy with or without tubal suturing
Number of subjects: 34
Study: 6342335

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily plus propantheline 45 mg daily (group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cimetidine 1 g daily plus placebo (group B)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg daily
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg at bedtime plus propantheline 45 mg daily
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Propantheline 90 mg daily
Number of subjects: 58
Study: 2412045

Group type: EXPERIMENTAL
Intervention: Ketanserin (10 mg i.v.)
Number of subjects: 10
Study: 28933977

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 26462903

Group type: EXPERIMENTAL
Intervention: Humeral intraosseous (HIO) epinephrine administration
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tibial intraosseous (TIO) epinephrine administration
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) epinephrine administration
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (i.v. with defibrillation but no epinephrine)
Number of subjects: 32
Study: 24655695

Group type: EXPERIMENTAL
Intervention: Impella 2.5
Number of subjects: 448

Group type: COMPARATOR
Intervention: Intra-Aortic Balloon Pump (IABP)
Number of subjects: 448
Study: 22498664

Group type: EXPERIMENTAL
Intervention: Strengthening group (n = 17)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Stretching group (n = 17)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Strengthening group vs Stretching group
Number of subjects: 50
Study: 20859144

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency ablation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Hydrothermablation
Number of subjects: 160
Study: 18492754

Group type: EXPERIMENTAL
Intervention: Twice-daily PTH 1-34
Number of subjects: 14

Group type: COMPARATOR
Intervention: Once-daily PTH 1-34
Number of subjects: 14
Study: 15979441

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 12823608

Group type: EXPERIMENTAL
Intervention: Chemotherapy and melatonin (20 mg/day orally in the evening)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Chemotherapy and melatonin
Number of subjects: 100
Study: 10672721

Group type: EXPERIMENTAL
Intervention: Perfusion of the kidney cavitary system with the drug Palisan
Number of subjects: 0
Study: 8729614

Group type: COMPARATOR
Intervention: Radiotherapy alone (extended fields)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Combined chemotherapy (CHOP or CHOP-like)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Combined therapy (radiotherapy followed by chemotherapy)
Number of subjects: 316
Study: 1923163

Group type: EXPERIMENTAL
Intervention: IV magnesium tocolysis for more than 7 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Gestational age-matched unexposed neonates
Number of subjects: 33
Study: 6616485

Group type: EXPERIMENTAL
Intervention: Nocardia rubra cell wall skeleton (N‐CWS)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control group (local chemotherapy with Adriamycin)
Number of subjects: 309
Study: 29332428

Group type: EXPERIMENTAL
Intervention: Standard care plus preoperative preparation (tour, cartoon video, familiarization with medical equipment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 29643055

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Education+Feedback
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 27136493

Group type: COMPARATOR
Intervention: Control
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Small changes
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Large changes
Number of subjects: 599